• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗哮喘的茶碱。

Theophylline for treatment of asthma.

作者信息

Weinberger M

出版信息

J Pediatr. 1978 Jan;92(1):1-7. doi: 10.1016/s0022-3476(78)80058-4.

DOI:10.1016/s0022-3476(78)80058-4
PMID:412935
Abstract

Theophylline has become useful not just as an acute bronchodilator, but also as a major prophylactic agent for the suppression of symptoms of chronic asthma. Efficacy and toxicity both relate closely to serum concentration. Variable elimination rates for the drug among individuals require careful individualization of dosage guided by measurement of serum theophylline concentration to maintain safe and effective serum theophylline concentrations. Fixed-dose combinations with ephedrine are more likely to add toxicity than benefit compared with theophylline alone if the latter is used in an adequate dose. Choices among the vase array of products available can be further simplified by considering cost and convenience of the various formulations. When used appropriately, theophylline has been successful in the essential elimination of asthmatic symptoms in over 70% of asthmatic children seen at a tertiary care referral center.

摘要

茶碱不仅已成为一种有效的急性支气管扩张剂,还成为抑制慢性哮喘症状的主要预防药物。其疗效和毒性都与血清浓度密切相关。个体间药物消除率存在差异,需要通过测定血清茶碱浓度来仔细调整剂量,实现个体化用药,以维持安全有效的血清茶碱浓度。与单独使用足够剂量的茶碱相比,茶碱与麻黄碱的固定剂量组合更可能增加毒性而非带来益处。考虑到各种制剂的成本和便利性,可以进一步简化在众多可用产品中的选择。正确使用时,在一家三级医疗转诊中心就诊的哮喘儿童中,超过70%使用茶碱后成功基本消除了哮喘症状。

相似文献

1
Theophylline for treatment of asthma.用于治疗哮喘的茶碱。
J Pediatr. 1978 Jan;92(1):1-7. doi: 10.1016/s0022-3476(78)80058-4.
2
Experience with theophylline for the management of chronic asthma.茶碱用于慢性哮喘管理的经验。
Eur J Respir Dis Suppl. 1980;109:120-33.
3
Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.用于慢性哮喘的茶碱:治疗原理、产品选择及给药方案
Pediatr Pharmacol (New York). 1983;3(3-4):273-85.
4
Interaction of ephedrine and theophylline.麻黄碱与茶碱的相互作用。
Clin Pharmacol Ther. 1975 May;17(5):585-92. doi: 10.1002/cpt1975175585.
5
Theophylline use: an overview.茶碱的使用:综述
J Allergy Clin Immunol. 1985 Aug;76(2 Pt 2):277-84. doi: 10.1016/0091-6749(85)90642-6.
6
[Treatment of bronchospastic attack and the asthmatic state].[支气管痉挛发作及哮喘状态的治疗]
Sov Med. 1977 Sep(9):117-22.
7
Relationship of serum theophylline concentration to inhibition of exercise-induced bronchospasm and comparison with cromolyn.血清茶碱浓度与运动诱发性支气管痉挛抑制作用的关系及与色甘酸的比较。
Pediatrics. 1977 Dec;60(6):840-4.
8
The relative merits of cromolyn sodium and high-dose theophylline therapy in childhood asthma.色甘酸钠与高剂量茶碱疗法在儿童哮喘治疗中的相对优点。
J Allergy Clin Immunol. 1980 Feb;65(2):97-104. doi: 10.1016/0091-6749(80)90192-x.
9
Theophylline and chlorpheniramine in childhood asthma. Dose requirements for children 6 to 12 years (therapeutic orphans) and young adults 13 to 18 years of age receiving cromolyn sodium prophylaxis.儿童哮喘中的茶碱和氯苯那敏。接受色甘酸钠预防治疗的6至12岁儿童(治疗孤儿)和13至18岁青少年的剂量需求。
Ann Allergy. 1974 Feb;32(2):73-9.
10
Bronchodilator therapy (second of two parts).支气管扩张剂治疗(两部分中的第二部分)
N Engl J Med. 1977 Oct 6;297(14):758-64. doi: 10.1056/NEJM197710062971405.

引用本文的文献

1
Serum level monitoring of a new slow release theophylline formulation in patients with chronic lung disease.慢性肺病患者中一种新型缓释茶碱制剂的血清水平监测
Br J Clin Pharmacol. 1980 Sep;10(3):265-71. doi: 10.1111/j.1365-2125.1980.tb01754.x.
2
Influence of food intake on bioavailability of theophylline in premature infants.食物摄入对早产儿茶碱生物利用度的影响。
Eur J Clin Pharmacol. 1982;22(2):171-3. doi: 10.1007/BF00542463.
3
Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pigs: anti-anaphylactic effects of sodium cromoglycate and aminophylline.
抗原诱导的主动致敏豚鼠支气管过敏反应:色甘酸钠和氨茶碱的抗过敏作用
Br J Pharmacol. 1980 Jul;69(3):467-72. doi: 10.1111/j.1476-5381.1980.tb07036.x.
4
Errors in the treatment of asthma.哮喘治疗中的错误。
Drugs. 1980 Feb;19(2):141-5. doi: 10.2165/00003495-198019020-00006.
5
Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.哮喘儿童中缓释型茶碱的生物利用度及吸收的昼夜变化
Eur J Clin Pharmacol. 1983;25(5):667-72. doi: 10.1007/BF00542356.
6
Cost-effectiveness of therapeutic drug monitoring.治疗药物监测的成本效益
Clin Pharmacokinet. 1987 Sep;13(3):131-40. doi: 10.2165/00003088-198713030-00001.
7
Dose-titration comparison of inhaled salbutamol and oral theophylline in asthma.哮喘患者吸入沙丁胺醇与口服茶碱的剂量滴定比较
Br J Clin Pharmacol. 1979 Dec;8(6):595-7. doi: 10.1111/j.1365-2125.1979.tb01052.x.
8
Comparison of IV salbutamol with IV aminophylline in severe acute asthma.静脉注射沙丁胺醇与静脉注射氨茶碱治疗重度急性哮喘的比较。
Arch Dis Child. 1979 Dec;54(12):983. doi: 10.1136/adc.54.12.983.
9
Clinical pharmacokinetics of theophylline.茶碱的临床药代动力学
Clin Pharmacokinet. 1978 Jul-Aug;3(4):267-93. doi: 10.2165/00003088-197803040-00002.